Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jake P Mann

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Expert Review of Clinical Pharmacology|August 15, 2017
The pharmacological management of NAFLD in children and adolescentsSavinda Liyanagedera, Robert Patrick Williams, Silvio Veraldi, et al.
Seminars in Liver Disease|February 23, 2018
Nonalcoholic Fatty Liver Disease in ChildrenJake P Mann, Luca Valenti, Eleonora Scorletti, et al.
Obesity Surgery|December 18, 2014
Systematic review of definitions of failure in revisional bariatric surgeryJake P Mann, Adam D Jakes, Jeremy D Hayden, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|June 16, 2016
Management and outcomes of neonates with down syndrome admitted to neonatal unitsJake P Mann, Eugene Statnikov, Neena Modi, et al.
Clinical and Molecular Hepatology|June 29, 2026
Genetic and Genomic Insights Across the SLD SpectrumJake P Mann, Karn Wijarnpreecha, Vitchapong Prasitsumrit, et al.
Journal of Hepatology|February 23, 2026
Updates in clinical medicine: MASLD in children and adolescentsSander Lefere, Bart G P Koot, Jake P Mann, et al.
Hepatology (Baltimore, Md.)|December 7, 2015
Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver diseaseJake P Mann, Rita De Vito, Antonella Mosca, et al.
HGG Advances|June 26, 2026
Multi-ancestry genome-wide association meta-analysis of hepatocellular carcinoma identifies eight risk loci including MAP3K9, DHRS1, MTTP, and 8q24.21Ifechukwuamaka Chinaka, Annabelle Schofield, Christopher I Amos, et al.
Plos One|October 27, 2020
Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factorsJake P Mann, Paul Carter, Matthew J Armstrong, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 27, 2024
FISPGHAN statement on the global public health impact of metabolic dysfunction-associated steatotic liver diseaseTania Mitsinikos, Marion M Aw, Robert Bandsma, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Expert Review of Clinical Pharmacology|August 15, 2017
The pharmacological management of NAFLD in children and adolescentsSavinda Liyanagedera, Robert Patrick Williams, Silvio Veraldi, et al.
Seminars in Liver Disease|February 23, 2018
Nonalcoholic Fatty Liver Disease in ChildrenJake P Mann, Luca Valenti, Eleonora Scorletti, et al.
Obesity Surgery|December 18, 2014
Systematic review of definitions of failure in revisional bariatric surgeryJake P Mann, Adam D Jakes, Jeremy D Hayden, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|June 16, 2016
Management and outcomes of neonates with down syndrome admitted to neonatal unitsJake P Mann, Eugene Statnikov, Neena Modi, et al.
Clinical and Molecular Hepatology|June 29, 2026
Genetic and Genomic Insights Across the SLD SpectrumJake P Mann, Karn Wijarnpreecha, Vitchapong Prasitsumrit, et al.
Journal of Hepatology|February 23, 2026
Updates in clinical medicine: MASLD in children and adolescentsSander Lefere, Bart G P Koot, Jake P Mann, et al.
Hepatology (Baltimore, Md.)|December 7, 2015
Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver diseaseJake P Mann, Rita De Vito, Antonella Mosca, et al.
HGG Advances|June 26, 2026
Multi-ancestry genome-wide association meta-analysis of hepatocellular carcinoma identifies eight risk loci including MAP3K9, DHRS1, MTTP, and 8q24.21Ifechukwuamaka Chinaka, Annabelle Schofield, Christopher I Amos, et al.
Plos One|October 27, 2020
Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factorsJake P Mann, Paul Carter, Matthew J Armstrong, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 27, 2024
FISPGHAN statement on the global public health impact of metabolic dysfunction-associated steatotic liver diseaseTania Mitsinikos, Marion M Aw, Robert Bandsma, et al.
Pageof 5